Table 3.
Prognostic factors in the Cox proportional hazards model
Variables | OS
|
|||||
---|---|---|---|---|---|---|
HR | Univariate 95% CI | Sig | HR | Multivariate 95% CI | Sig | |
Gender | ||||||
Male vs female | 1.232 | 0.528–1.312 | 0.782 | |||
Age | ||||||
<50 vs ≥50 | 0.982 | 0.785–2.201 | 0.936 | |||
Smoking | ||||||
No vs yes | 2.723 | 1.823–4.192 | 0.021 | 3.556 | 2.238–3.984 | 0.152 |
pT | ||||||
T1–2 vs T3–4 | 3.112 | 2.230–4.762 | 0.002* | 5.397 | 3.343–7.842 | 0.0001* |
Histology | ||||||
Squamous vs adenocarcinoma | 1.274 | 0.542–2.723 | 0.803 | |||
TNM stage | ||||||
I–II vs III–IV | 1.682 | 0.926–2.698 | 0.437 | |||
Differentiation | ||||||
Low vs moderate-high | 2.091 | 1.134–2.803 | 0.182 | |||
LNM | ||||||
− vs + | 1.892 | 1.117–2.437 | 0.235 | |||
CDR1as expression | ||||||
Low vs high | 3.583 | 1.668–4.826 | 0.006* | 6.132 | 2.923–7.556 | 0.0001* |
Note:
P < 0.05.
Abbreviations: CI, confidence interval; HR, hazard ratio; LNM, lymph node metastasis; OS, overall survival.